Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00943176 · ClinicalTrials.gov registry record · Phase 1
Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00943176: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT00943176 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00943176, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of modafinil in the treatment of fatigue in patients with Primary Biliary Cirrhosis. The general aim of the study is to identify a safe and effective therapy for fatigue in patients with primary biliary cirrhosis.
Interventions
- DRUG Modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00943176
The ClinicalTrials.gov registry entry for NCT00943176 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Modafinil is the first listed.
NCT00943176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00943176 about?
NCT00943176 is a clinical study titled "Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)". The purpose of this study is to evaluate the use of modafinil in the treatment of fatigue in patients with Primary Biliary Cirrhosis. The general aim of the study is to identify a safe and effective therapy for fatigue in patients with primary biliary cirrhosis.
What is the current status of trial NCT00943176?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2009-06. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00943176?
The interventions under investigation include: Modafinil (DRUG).
Who is sponsoring clinical trial NCT00943176?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.